Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The Role of IGF-1 and IL-10 in Childhood Stunting: Evidence From Indonesia.

Created on 13 Aug 2026

Authors

Putriatri Krimasusini Senudin, Irwanto, Nur Aisiyah Widjaja, Sulistiawati

Published in

TheScientificWorldJournal. Volume 2026. Issue 1. Pages e1029295.

Abstract

Stunting remains a pressing public health problem in low- and middle-income countries. The specific biochemical roles of growth- and immune-related biomarkers with stunting are less understood. This study is aimed at investigating the contribution of insulin-like growth factor 1 (IGF-1) and interleukin-10 (IL-10) to stunting among Indonesian children. A case-control design was employed involving 80 children aged 24-60 months in Manggarai, Indonesia (40 stunted and 40 nonstunted), matched by age, sex, and residence. Data were collected through anthropometric measurements, household surveys, structured interviews, and biochemical analysis of serum IGF-1 and IL-10 using ELISA. Findings revealed that stunted children had significantly lower IGF-1 levels (11.963 ± 8.658 vs. 18.000 ± 15.238, p < 0.05) and higher IL-10 levels (317.841 ± 214.934 vs. 543.605 ± 416.837, p < 0.05) compared with controls. The study concludes that effective stunting prevention requires integrated interventions addressing both nutritional adequacy and infection control in early childhood.

PMID:
42593297
Bibliographic data and abstract were imported from PubMed on 13 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement